News
CDC panel says no to thimerosal in flu vaccines, recommends new RSV shot
Taking aim at a longtime target of anti-vaccine activists, CDC advisors said Thursday that the U.S. should not administer influenza vaccines containing thimerosal, a mercury-based preservative used to protect multi-dose vials of vaccine.
News-Medical.Net on MSN41m
How underreporting masks the real impact of RSV in older populationsResearch shows RSV leads to high hospitalization rates in adults, emphasizing the importance of enhanced surveillance and ...
Colds and flu often cause sore throats that make swallowing and talking uncomfortable, while RSV in adults and older children usually mimics a mild cold. Cepacol® explores why sore throats are more ...
A newly configured federal vaccine panel's June 25 action is expected to improve options to protect infants from potentially ...
Opinion
The economics of prevention: How maternal RSV immunisation can strengthen public health systemsWhile respiratory syncytial virus (RSV) typically causes mild symptoms in adults, the virus can be life-threatening for infants. The seasonal virus is the most common cause of lower respiratory tract ...
The FDA delivered two notable approvals for RSV immunization, UroGen overcame a negative advisory committee vote to secure an ...
MedPage Today on MSN4d
Kennedy's ACIP Backs Monoclonal Antibody for RSV Prevention in InfantsThe CDC's newly reconstituted Advisory Committee on Immunization Practices (ACIP) voted 5-2 in support of infants younger ...
Dr. Levi and Vicky Pebsworth, a nurse affiliated with an anti-vaccine group, voted against recommending clesrovimab; the ...
RSV seasons ended earlier than usual in 2022-23 and 2023-24, and typical human hMPV circulation patterns have returned since the COVID-19 pandemic.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback